EYEOP1 is a novel medical device developed by EyeTechCare, a system delivering non-invasive treatment for refractory glaucoma. This treatment can be administered on an outpatient basis and is performed under local anaesthaesia. The patient simply lies down close to the command module and a disposable therapy device is placed on the globe of the eyeball. The therapeutic phase of the procedure lasts only a minute and the procedure itself can be performed outside of the operating theatre in, for example, an examination room or medical consulting rooms. EyeTechCare holds a portfolio of 5 patents on this new treatment system.
- Control: : ultrasound-guided
- Type of therapy: : for glaucoma treatment
- System type: : HIFU ablation system